Table: Daito - 6-MTH group results

Daito Pharmaceutical

14/01/2020 06:00

Jan 14 (Reuters)- 
             Daito Pharamaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   6 months ended      6 months ended       Year to 
                  Nov 30, 2019        Nov 30, 2018     May 31, 2020 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               23.25               20.15            43.50    
                   (+15.4 pct)         (-1.5 pct)       (+5.7 pct)  
  Operating            2.83                2.33             4.70    
                   (+21.6 pct)         (+2.7 pct)       (+3.4 pct)  
  Recurring            2.88                2.37             4.75    
                   (+21.4 pct)         (+2.8 pct)       (+2.3 pct)  
  Net                  2.00                1.67             3.30    
                   (+19.7 pct)         (+5.5 pct)       (-6.1 pct)  
  EPS              159.48 yen          133.74 yen       263.71 yen  
  EPS Diluted      158.58 yen                                       
  Ann Div                               38.00 yen        40.00 yen  
  -Q2 div           20.00 yen           18.00 yen                   
  -Q4 div                               20.00 yen        20.00 yen  
  
  NOTE - Daito Pharamaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4577.T